422 related articles for article (PubMed ID: 27431347)
1. The Proteomics of Saliva in Sjögren's Syndrome.
Katsiougiannis S; Wong DT
Rheum Dis Clin North Am; 2016 Aug; 42(3):449-56. PubMed ID: 27431347
[TBL] [Abstract][Full Text] [Related]
2. Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjögren's syndrome.
Baldini C; Gallo A; Perez P; Mosca M; Alevizos I; Bombardieri S
Clin Exp Rheumatol; 2012; 30(5):785-90. PubMed ID: 23009763
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.
Aqrawi LA; Galtung HK; Vestad B; Øvstebø R; Thiede B; Rusthen S; Young A; Guerreiro EM; Utheim TP; Chen X; Utheim ØA; Palm Ø; Jensen JL
Arthritis Res Ther; 2017 Jan; 19(1):14. PubMed ID: 28122643
[TBL] [Abstract][Full Text] [Related]
4. Proteomic and histopathological characterisation of sicca subjects and primary Sjögren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers.
Aqrawi LA; Galtung HK; Guerreiro EM; Øvstebø R; Thiede B; Utheim TP; Chen X; Utheim ØA; Palm Ø; Skarstein K; Jensen JL
Arthritis Res Ther; 2019 Jul; 21(1):181. PubMed ID: 31366407
[TBL] [Abstract][Full Text] [Related]
5. [Sjögren's syndrome (SS), a review of the subject and saliva as a diagnostic method].
Riega-Torres JC; Villarreal-Gonzalez AJ; Ceceñas-Falcon LÁ; Salas-Alanis JC
Gac Med Mex; 2016; 152(3):371-80. PubMed ID: 27335194
[TBL] [Abstract][Full Text] [Related]
6. Investigation of three potential autoantibodies in Sjogren's syndrome and associated MALT lymphoma.
Cui L; Elzakra N; Xu S; Xiao GG; Yang Y; Hu S
Oncotarget; 2017 May; 8(18):30039-30049. PubMed ID: 28404907
[TBL] [Abstract][Full Text] [Related]
7. Cytokines in Sjögren's syndrome.
Roescher N; Tak PP; Illei GG
Oral Dis; 2009 Nov; 15(8):519-26. PubMed ID: 19519622
[TBL] [Abstract][Full Text] [Related]
8. Abnormal distribution of AQP4 in minor salivary glands of primary Sjögren's syndrome patients.
Sisto M; Lorusso L; Ingravallo G; Nico B; Ribatti D; Ruggieri S; Lofrumento DD; Lisi S
Autoimmunity; 2017 Jun; 50(4):202-210. PubMed ID: 28648105
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes.
Baldini C; Giusti L; Ciregia F; Da Valle Y; Giacomelli C; Donadio E; Sernissi F; Bazzichi L; Giannaccini G; Bombardieri S; Lucacchini A
Arthritis Res Ther; 2011; 13(6):R194. PubMed ID: 22117835
[TBL] [Abstract][Full Text] [Related]
10. Thymosin β
Bosello S; Peluso G; Iavarone F; Tolusso B; Messana I; Faa G; Castagnola M; Ferraccioli G
Arthritis Res Ther; 2016 Oct; 18(1):229. PubMed ID: 27716395
[TBL] [Abstract][Full Text] [Related]
11. Proteomic diagnosis of Sjögren's syndrome.
Giusti L; Baldini C; Bazzichi L; Bombardieri S; Lucacchini A
Expert Rev Proteomics; 2007 Dec; 4(6):757-67. PubMed ID: 18067414
[TBL] [Abstract][Full Text] [Related]
12. The role of muscarinic acetylcholine receptor type 3 polypeptide (M3RP205-220) antibody in the saliva of patients with primary Sjögren's syndrome.
He J; Qiang L; Ding Y; Wei P; Li YN; Hua H; Li ZG
Clin Exp Rheumatol; 2012; 30(3):322-6. PubMed ID: 22510450
[TBL] [Abstract][Full Text] [Related]
13. Proteomics of saliva, plasma, and salivary gland tissue in Sjögren's syndrome and non-Sjögren patients identify novel biomarker candidates.
Sembler-Møller ML; Belstrøm D; Locht H; Pedersen AML
J Proteomics; 2020 Aug; 225():103877. PubMed ID: 32540407
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Lipids in Saliva, Tears and Minor Salivary Glands of Sjögren's Syndrome Patients Using an HPLC/MS-Based Approach.
Fineide F; Chen X; Bjellaas T; Vitelli V; Utheim TP; Jensen JL; Galtung HK
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445702
[TBL] [Abstract][Full Text] [Related]
15. B-cell hyperactivity in primary Sjögren's syndrome.
Kroese FG; Abdulahad WH; Haacke E; Bos NA; Vissink A; Bootsma H
Expert Rev Clin Immunol; 2014 Apr; 10(4):483-99. PubMed ID: 24564507
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of antiperinuclear factor in primary Sjogren's syndrome].
Varshavskaia AA; Shilkina NP; Baranov AA; Makarushin AA
Klin Lab Diagn; 2000 Jan; (1):35-7. PubMed ID: 10878900
[No Abstract] [Full Text] [Related]
17. Characterization of Extracellular Vesicle Cargo in Sjögren's Syndrome through a SWATH-MS Proteomics Approach.
Finamore F; Cecchettini A; Ceccherini E; Signore G; Ferro F; Rocchiccioli S; Baldini C
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064456
[TBL] [Abstract][Full Text] [Related]
18. Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: a preliminary study.
Streckfus C; Bigler L; Navazesh M; Al-Hashimi I
Clin Oral Investig; 2001 Jun; 5(2):133-5. PubMed ID: 11480812
[TBL] [Abstract][Full Text] [Related]
19. A re-evaluation of anti-NA-14 antibodies in patients with primary Sjögren's syndrome: Significant role of interferon-γ in the production of autoantibodies against NA-14.
Uomori K; Nozawa K; Ikeda K; Doe K; Yamada Y; Yamaguchi A; Fujishiro M; Kawasaki M; Morimoto S; Takamori K; Sekigawa I; Chan EK; Takasaki Y
Autoimmunity; 2016 Aug; 49(5):347-56. PubMed ID: 27328271
[TBL] [Abstract][Full Text] [Related]
20. Increase in acrolein-conjugated immunoglobulins in saliva from patients with primary Sjögren's syndrome.
Hirose T; Saiki R; Uemura T; Suzuki T; Dohmae N; Ito S; Takahashi H; Ishii I; Toida T; Kashiwagi K; Igarashi K
Clin Chim Acta; 2015 Oct; 450():184-9. PubMed ID: 26301996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
